Your browser doesn't support javascript.
loading
Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions.
Gibson, Peter G; Prazma, Charlene M; Chupp, Geoffrey L; Bradford, Eric S; Forshag, Mark; Mallett, Stephen A; Yancey, Steve W; Smith, Steven G; Bel, Elisabeth H.
Afiliación
  • Gibson PG; School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.
  • Prazma CM; Respiratory Medical Franchise, GSK, Research Triangle Park, NC, USA. charlene.m.prazma@gsk.com.
  • Chupp GL; GSK, 5 Moore Drive, PO Box 13398, Research Triangle Park, NC, 27709-3398, USA. charlene.m.prazma@gsk.com.
  • Bradford ES; Yale Center for Asthma and Airways Disease (YCAAD), Yale School of Medicine, New Haven, CT, USA.
  • Forshag M; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA.
  • Mallett SA; Respiratory Medical Franchise, GSK, Research Triangle Park, NC, USA.
  • Yancey SW; Clinical Statistics, GSK, Stockley Park, Uxbridge, Middlesex, UK.
  • Smith SG; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA.
  • Bel EH; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA.
Respir Res ; 22(1): 171, 2021 Jun 07.
Article en En | MEDLINE | ID: mdl-34098955

Texto completo: 1 Colección: 01-internacional Asunto principal: Asma / Volumen Espiratorio Forzado / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Diagnostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Respir Res Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Asunto principal: Asma / Volumen Espiratorio Forzado / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Diagnostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Respir Res Año: 2021 Tipo del documento: Article País de afiliación: Australia